as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
0.72%
Downside
6.52%
Upside
52 Week's Low
52 Week's High
33.70%
Downside
171.01%
Upside
Check Immunitybio Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.6B
EPS (TTM)
-0.4433
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.43
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
0EBITDA
-269.1M
Revenue (TTM)
56.6M
Profit Margin
0.00%
Return On Equity TTM
425479700.00%
Track how Immunitybio Inc. P/E has moved over time to understand its valuation trends.
Immunitybio Inc. in the last 5 years
Lowest (0.00x)
September 17, 2025
Today (-4.43x)
September 17, 2025
Industry (10.13x)
September 17, 2025
Highest (0.00x)
September 17, 2025
Today’s Price to Earnings Ratio: -4.43x
Compare market cap, revenue, PE, and other key metrics of Immunitybio Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.6B | NA | -4.43 | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Immunitybio Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Immunitybio Inc. investment value today
Current value as on today
₹87,731
Returns
Returns from Immunitybio Inc. Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 8 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Immunitybio Inc.. Average target price of $10.2
Get share price movements and forecasts by analysts on Immunitybio Inc..
What analysts predicted
72.94%UPSIDE
Target Price
$10.2
Current Price
$2.76
Analyzed by
8 Analysts
Target
$10.20
Immunitybio Inc. target price $10.2, a slight upside of 72.94% compared to current price of $2.76. According to 8 analysts rating.
Investment in Immunitybio Inc. Shares on INDmoney has dropped by -11.25% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Immunitybio Inc. Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:52% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, -129.64M → -92.55M (in $), with an average increase of 40.1% per quarter
Revenue Rich
Revenue is up for the last 6 quarters, 40.0K → 26.42M (in $), with an average increase of 58.0% per quarter
Price Rise
In the last 7 days, IBRX stock has moved up by 8.5%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 170.1%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 86.7%
Organisation | Immunitybio Inc. |
Headquarters | 3530 John Hopkins Court, San Diego, CA, United States, 92121 |
Industry | Healthcare |
CEO | Mr. Richard Gerald Adcock |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Leonard S. Sender M.D. | Chief Medical Officer of Liquid Tumors & Cell Therapy |
Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., M.Sc. | Executive Chairman of the Board and Global Chief Scientific & Medical Officer |
Mr. Richard Gerald Adcock | President, CEO & Director |
Ms. Regan J. Lauer | Chief Accounting Officer |
Dr. Enrique Diloné Ph.D., RAC | Chief Technology Officer |
Mr. Jason R. Liljestrom J.D. | General Counsel & Corporate Secretary |
Ms. Sarah Singleton | Chief Communications Officer & Head of Patient Advocacy |
Dr. Sandeep K. Reddy M.D. | Chief Medical Officer |
Mr. David C. Sachs | Chief Financial Officer |
Dr. Barry J. Simon M.D. | Chief Corporate Affairs Officer & Director |
Immunitybio Inc. share price today is $2.76 as on at the close of the market. Immunitybio Inc. share today touched a day high of $2.94 and a low of $2.74.
Immunitybio Inc. share touched a 52 week high of $7.48 on and a 52 week low of $1.83 on . Immunitybio Inc. stock price today i.e. is closed at $2.76,which is 63.10% down from its 52 week high and 50.82% up from its 52 week low.
Immunitybio Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Immunitybio Inc. (IBRX) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Immunitybio Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Immunitybio Inc. share’s latest price of $2.76 as on September 18, 2025 at 1:29 am IST, you will get 3.6232 shares of Immunitybio Inc.. Learn more about
fractional shares .